The UNC Eshelman School of Pharmacy (www.pharmacy.unc.edu) is one of five health science schools (Pharmacy, Nursing, Dentistry, Public Health, Medicine) at the University of North Carolina at Chapel Hill and is one of the oldest health science academic programs at Chapel Hill. The School teaches approximately 600 PharmD students, 100 PhD students, and 20 Master's students. The School has built a reputation for its continued pursuit of excellence, rigorous education and training programs, cutting-edge multidisciplinary research, progressive pharmacy practices, efficient business operations, and its outstanding faculty, staff, and students. The School was named the number one School of Pharmacy in the U.S. by the U.S. News and World Report. The School has experienced unprecedented growth and success and continues to strategically position itself for sustained impact, as articulated in the School's Strategic Plan (https://pharmacy.unc.edu/about/ospa/strategic-plan/)

Our vision is to be the preeminent school of pharmacy where leaders in practice, education, and research are developed and nurtured. We are Advancing Medicine for Life through innovation and collaboration in pharmacy practice, education, research, and public service.

The UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program
is a collaboration between the UNC Eshelman School of Pharmacy and the Duke
Clinical Research Institute to prepare clinician-scientists to become leaders in clinical
pharmacology research.

This two-year program meets the fellowship training expectations set forth by the
American Board of Clinical Pharmacology and is a registered member of ABCP.

Clinical pharmacology, in the broadest sense, encompasses drug discovery, clinical
development, regulatory issues, therapeutic use and individualization of drug therapy,
optimization of drug dosage regimens, an understanding of drug-induced toxicity, and
measures to prevent or minimize adverse effects of drugs.

Postdoctoral trainee will have completed highly relevant doctoral training in pharmaceutical or medical area M.D., Pharm.D., D.D.S.

- Full understanding of framing research question, research design and methods, and
project implementation.
- Demonstrated proficiency in scientific/manuscript writing, grant writing, poster and oral
presentations.

- Preferred candidates will have strong publication record and demonstrated experience
in research study design and project implementation.
- Preferred candidates will have strong publication record and demonstrated experience in research study design and project implementation.

Please apply online at
and attach the

following documents:

This is a NIH sponsored T32 postdoctoral training program and all applicants must be

either US citizens, non-citizen nationals or US permanent residents with evidence of

superior academic performance, previous research or clinical experience and

publications.

For information on UNC Postdoctoral Benefits and Services

If you experience any problems accessing the system or have questions about the application process, please contact the University's Equal Employment Opportunity office at (919) 966-3576 or send an email to equalopportunity@unc.edu.

Please note: The Equal Employment Opportunity office will not be able to provide specific updates regarding position or application status.

The University of North Carolina at Chapel Hill is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to age, color, disability, gender, gender expression, gender identity, genetic information, race, national origin, religion, sex, sexual orientation, or status as a protected veteran.